Clinical study of Xuanbi Tongmai Decoction combined with atenolol in treating Qi deficiency and blood stasis syndrome of acute myocardial infarction
Objective:To investigate the clinical effect of Xuanbi Tongmai Decoction combined with atenolol in patients with Acute myocardial infarction(AMI)syndrome of qi deficiency and blood stasis.Methods:70 patients with AMI syndrome of Qi deficiency and blood stasis who received treatment in our hospital from January 2021 to December 2022 were included.They were randomly divided into control group and observation group,35 cases each.The control group was treated with atenolol.Observation group was treated with Xuanbi Tongmai decoction on the basis of control group.TCM syndrome score,cardiac function index and adverse reactions during treatment were analyzed and compared between the two groups.Results:After treatment,the symptom score of observation group was significantly lower than that of control group(P<0.05).After treatment,the level of cardiac function indexes in the observation group was significantly higher than that in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion:Xuanbi Tongmai Decoction combined with atenolol in the treatment of AMI qi deficiency and blood stasis can improve heart function,relieve clinical symptoms,and have good safety.
NETL
NSTL
万方数据
